Skip to main content

Table 2 The KEGG pathways enriched by the potential target genes of miR-542-5p

From: The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model

ID Description Count in gene set p-value
hsa05032 Morphine addiction 11 0.000111
hsa04024 cAMP signaling pathway 15 0.000587
hsa04261 Adrenergic signaling in cardiomyocytes 12 0.001364
hsa04727 GABAergic synapse 9 0.001523
hsa05030 Cocaine addiction 7 0.001541
hsa04390 Hippo signaling pathway 12 0.001790
hsa04725 Cholinergic synapse 10 0.002243
hsa04724 Glutamatergic synapse 10 0.002693
hsa05200 Pathways in cancer 21 0.002768
hsa04923 Regulation of lipolysis in adipocytes 7 0.003081
hsa05414 Dilated cardiomyopathy 8 0.005886
hsa04911 Insulin secretion 8 0.006278
hsa04921 Oxytocin signaling pathway 11 0.007747
hsa04976 Bile secretion 7 0.008632
hsa04520 Adherens junction 7 0.009886
  1. Enriched by DAVID, p < 0.01